124 related articles for article (PubMed ID: 38376304)
1. Outcomes of hypofractionation for early-stage glottic carcinoma.
Uysal B; Gamsiz H; Colak O; Beyzadeoglu M
J Cancer Res Ther; 2023 Oct; 19(7):1962-1966. PubMed ID: 38376304
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
[TBL] [Abstract][Full Text] [Related]
4. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionation reduces the therapeutic ratio in early glottic carcinoma.
Harrison D; Crennan E; Cruickshank D; Hughes P; Ball D
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):365-72. PubMed ID: 3403317
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study.
Kachhwaha A; Jakhar SL; Syiem T; Sharma N; Kumar HS; Sharma A
J Cancer Res Ther; 2021; 17(6):1499-1502. PubMed ID: 34916384
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
[TBL] [Abstract][Full Text] [Related]
8. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
9. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
10. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer.
Kim KN; Dyer MA; Qureshi MM; Shah NK; Grillone GA; Faden DL; Jalisi SM; Truong MT
Am J Otolaryngol; 2020; 41(5):102544. PubMed ID: 32505989
[TBL] [Abstract][Full Text] [Related]
12. Clinical radiobiology of glottic T1 squamous cell carcinoma.
Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
[TBL] [Abstract][Full Text] [Related]
13. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
14. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
15. Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients.
Sapienza LG; Ning MS; Taguchi S; Calsavara VF; Pellizzon ACA; Gomes MJL; Kowalski LP; Baiocchi G
Oral Oncol; 2019 Jun; 93():8-14. PubMed ID: 31109700
[TBL] [Abstract][Full Text] [Related]
16. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
[TBL] [Abstract][Full Text] [Related]
19. Conventional fractionation should not be the standard of care for T2 glottic cancer.
Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
[TBL] [Abstract][Full Text] [Related]
20. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
